Analyzing OptimizeRx (NASDAQ:OPRX) and Manhattan Associates (NASDAQ:MANH)

Manhattan Associates (NASDAQ:MANH) and OptimizeRx (NASDAQ:OPRX) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Manhattan Associates and OptimizeRx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Manhattan Associates	0	6	7	1	2.64
OptimizeRx	1	3	7	0	2.55

Manhattan Associates currently has a consensus target price of $222.42, indicating a potential upside of 26.38%. OptimizeRx has a consensus target price of $16.88, indicating a potential upside of 27.90%. Given OptimizeRx’s higher possible upside, analysts plainly believe OptimizeRx is more favorable than Manhattan Associates.

Institutional and Insider Ownership

98.5% of Manhattan Associates shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 0.7% of Manhattan Associates shares are held by insiders. Comparatively, 5.6% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

Manhattan Associates has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

Profitability

This table compares Manhattan Associates and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Manhattan Associates	20.25%	78.80%	29.95%
OptimizeRx	0.03%	6.37%	4.46%

Valuation & Earnings

This table compares Manhattan Associates and OptimizeRx”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Manhattan Associates	$1.04 billion	10.17	$218.36 million	$3.51	50.14
OptimizeRx	$109.51 million	2.25	-$18.66 million	N/A	N/A

Manhattan Associates has higher revenue and earnings than OptimizeRx.

Summary

Manhattan Associates beats OptimizeRx on 10 of the 13 factors compared between the two stocks.

About Manhattan Associates

Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations. It offers Warehouse Management Solution for managing goods and information across the distribution centers; Manhattan Active Warehouse Management, a cloud native and version less application for the associate; and Transportation Management Solution for helping shippers navigate their way through the demands and meet customer service expectations at the lowest possible freight costs; Manhattan SCALE, a portfolio of logistics execution solution; and Manhattan Active Omni, which offers order management, store inventory and fulfillment, POS, and customer engagement tools for enterprises and stores. The company also provides inventory optimization and allocation solutions; technology platform including Manhattan Active Platform solutions, a cloud-native product designed to provide version-less product access; maintenance services, which offers on-premises software licensees with software upgrades for additional or improved functionality and technological advances; and professional services, such as solutions planning and implementation, and related consulting services. In addition, it provides training and change management services; and resells computer hardware, radio frequency terminal networks, radio frequency identification chip readers, bar code printers and scanners, and other peripherals. The company offers products through direct sales personnel and partnership agreements with various organizations. It serves retail, consumer goods, food and grocery, logistics service providers, industrial and wholesale, high technology and electronics, life sciences, and government industries. The company operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.